J&J Seeks Billions in Trial Over Decade-Old Bidding War

Johnson & Johnson asked a judge to rule that it’s owed $7.2 billion by Boston Scientific Corp. at the end of a trial over its failed effort a decade ago to acquire heart device-maker Guidant Corp.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.